Gout (Chronic Refractory) Market Assessment 2024 Featuring 15 Companies and 20 Key Drugs - Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access
September 30, 2024 05:35 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Gout (Chronic Refractory) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has...
Pericarditis Drugs Global Strategic Business Report 2023-2030: Patent Expiries and Surge of Generics in the Market, Increasing Incidence of Cardiac Disorders Driving Demand
August 16, 2024 09:48 ET
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Pericarditis Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Pericarditis...
Gout Therapeutics Market to Grow at a CAGR of 8.4% during the 2022 to 2031 Forecast Period: TMR Study
July 28, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 28, 2023 (GLOBE NEWSWIRE) -- The global gout therapeutics market stood at US$ 2.2 billion in 2021 and the global market is projected to reach US$ 4.9...